While data has been mainly retrospective, it has ranged from specific patient groups, such as those with hormone receptorpositive disease receiving endocrine therapy 1 or those only receiving semaglutide and tirzepatide with stage I to III breast cancer, 2 to patients from the broader breast cancer population receiving a range of GLP-1 agonists
Step 2: Online Consultation A telehealth session follows, where a licensed provider evaluates your BMI, medical condition, weight goals, and existing treatments to select an appropriate medication
Both medications help regulate appetite and blood sugar they work a little differently
Patients who were taking weekly injectable semaglutide from overseas clinics need to switch to an alternative available in Singapore
Step Therapy: This is another cost-control measure
[DOI] [PubMed] [Google Scholar] 57.Ying W., Riopel M., Bandyopadhyay G., Dong Y., Birmingham A., Seo J.B., Ofrecio J.M., Wollam J., Hernandez-Carretero A., Fu W., et al
